PURE Bioscience, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures
PURE Bioscience, Inc. (PURE) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures of 6.67 million shares for the 3-month period ending 2019-10-31, per its 10-Q filed 2019-12-13.
Discontinued › Shareholders' Equity › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Net of Forfeitures
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod · last filed 2019-12-13
- PURE Bioscience, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, net of forfeitures for the quarter ending 2019-10-31 was 6.67M shares.
- PURE Bioscience, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, net of forfeitures for the quarter ending 2019-07-31 was -247.34K shares.
- PURE Bioscience, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, net of forfeitures for the quarter ending 2019-04-30 was 223.75K shares.
- PURE Bioscience, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, net of forfeitures for fiscal 2019 was 6.35M shares.
- PURE Bioscience, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, net of forfeitures for fiscal 2014 was 300.00K shares, a 9.89% increase from fiscal 2013.
- PURE Bioscience, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, net of forfeitures for fiscal 2013 was 273.00K shares, a 572.00% increase from fiscal 2012.
- PURE Bioscience, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, net of forfeitures for fiscal 2012 was 40.63K shares, a 46.28% decline from fiscal 2011.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures 12 month |
|---|---|---|---|---|
| 2019-10-31 | 6.67M shares 10-Q · filed 2019-12-13 | 6.42M shares derived: sum of 2 quarters · filed 2019-12-13 | 6.64M shares derived: sum of 3 quarters · filed 2019-12-13 | |
| 2019-07-31 | -247.34K shares derived: 10-K 12 month − 10-Q 9 month · filed 2019-10-30 | -23.59K shares derived: sum of 2 quarters · filed 2019-10-30 | 6.35M shares 10-K · filed 2019-10-30 | |
| 2019-04-30 | 223.75K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2019-06-13 | 6.60M shares 10-Q · filed 2019-06-13 | ||
| 2019-01-31 | 6.38M shares 10-Q · filed 2019-03-06 | |||
| 2014-07-31 | 300.00K shares 10-K · filed 2015-10-28 | |||
| 2013-07-31 | 273.00K shares 10-K · filed 2014-10-28 | |||
| 2012-07-31 | 40.63K shares 10-K · filed 2013-10-24 | |||
| 2011-07-31 | 75.63K shares 10-K · filed 2012-10-29 |